I seen what happened at $95, the FDA response, and how people responded to lockup expiration + the secondary offering. People reacted quickly, things got tense, and now the storm will soon calm. The point is, it very recently hit a new high, and a new high will happen likely really soon. Once $115 passes, my new target is $200. I believe this is feasible if single source FDA approval is within a timely manner. They also have factories and deployments. I am looking constantly at institutional activity, and that is what excites me the most trend-wise. That said, please invest at your own risk and do your own due diligence. Everything I say is on an opinion based basis.